{"id":"W4311165255","doi":"10.1182/blood-2022-171751","title":"Consolidation Therapy with Blinatumomab Improves Overall Survival in Newly Diagnosed Adult Patients with B-Lineage Acute Lymphoblastic Leukemia in Measurable Residual Disease Negative Remission: Results from the ECOG-ACRIN E1910 Randomized Phase III National Cooperative Clinical Trials Network Trial","year":2022,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":75,"is_retracted":false,"has_abstract":true,"ca_institutions":"Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Medicine; Blinatumomab; Minimal residual disease; Internal medicine; Induction chemotherapy; Chemotherapy regimen; Chemotherapy; Rituximab; Oncology; Gastroenterology; Surgery; Leukemia; Lymphoblastic Leukemia; Lymphoma","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.01083852,0.0005917733,0.002324797,0.0002305464,0.0004371955,0.0001344613,0.0004733146,0.000199031,0.0001579308],"category_scores_gemma":[0.03175681,0.0003469253,0.0002839604,0.001073546,0.000553323,0.0003146498,0.0002185886,0.001256327,0.000005186888],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001688278,"about_ca_system_score_gemma":0.01107352,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001229649,"about_ca_topic_score_gemma":0.0003659255,"domain_scores_codex":[0.9833169,0.009307805,0.002781395,0.001218654,0.002616963,0.0007582894],"domain_scores_gemma":[0.955507,0.040074,0.001543138,0.0008408074,0.001449272,0.0005857164],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.983695,0.004639743,0.002503059,0.000009602179,0.001275997,0.0006562375,0.001047168,0.003272245,0.00009594195,0.00007984011,0.002224988,0.0005001882],"study_design_scores_gemma":[0.9686654,0.004873525,0.009894134,0.0003650044,0.0007301935,0.000008851048,0.0003552623,0.01413316,0.0002904582,0.0001730699,0.0000807576,0.000430205],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9870743,0.00015487,0.000138665,0.001117843,0.0004175278,0.00938233,0.001417796,0.00006386186,0.0002328384],"genre_scores_gemma":[0.992176,0.0002705155,0.0005902735,0.0009046271,0.001196703,0.001822868,0.002728246,0.00008722987,0.0002235466],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0307662,"threshold_uncertainty_score":0.9998983,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04284867665052221,"score_gpt":0.3463355024982483,"score_spread":0.3034868258477261,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}